ALR Technologies Announces their ALRT Diabetes Solution Provides Telehealth Service Opportunities for Physicians and their Patients

Nachrichtenquelle: globenewswire
23.03.2020, 13:30  |  119   |   |   

The Coronavirus (COVID-19) pandemic highlights the need for and benefits of Telehealth

RICHMOND, Va., March 23, 2020 (GLOBE NEWSWIRE) -- ALR Technologies, Inc. (“ALRT”) (OTCPINK: ALRT), the diabetes management company, announces their ALRT Diabetes Solution platform provides the tools physicians need to offer telehealth, telemedicine, and remote patient monitoring services to their patients with diabetes. The expanded reimbursements for telehealth services, recently announced by the Centers for Medicare and Medicaid Services (CMS) due to the coronavirus outbreak, is especially helpful to physicians and their patients during the pandemic.

Telehealth services help physicians extend care to patients who live in remote areas or who cannot physically come into the clinic for routine office visits. It also increases the efficiency of physicians and their staff. During the current pandemic, telehealth services can reduce exposure risk to coronavirus and other communicable infections by treating patients at home rather than at the doctor’s office.

The ALRT Diabetes Solution allows patients to upload the blood glucose data from meters provided by ALRT on a weekly basis. The system processes and converts each data set to a Predictive A1C value and shares it with the patient’s physician. The ALRT algorithm then sends the physician therapy advancement suggestions based on current clinical practice guidelines. Patients receive therapy assessments and adjustments in much shorter cycles than with any other care model, keeping A1Cs on target, mitigating diabetes complications, and lowering costs of care. Physicians can utilize the ALRT system for telehealth with all their diabetes patients, regardless of their disease classification, including patients with prediabetes.

ALRT has been at the cutting edge of telehealth innovation since they began focusing on remote diabetes care in 2005. Although CMS and a few commercial health plans recognize the benefits of telehealth, there have been enough restrictions in the marketplace to prevent its broad implementation. The public health priorities due to the Coronavirus pandemic have changed the reimbursement landscape in favor of telehealth providers. Companies that have been in discussion with ALRT regarding implementation of their Diabetes Solution are becoming aware of the telehealth implications of using this system, in addition to the other benefits.

Seite 1 von 2
ALR Technologies Aktie jetzt ab 0€ handeln - auf Smartbroker.de



Diesen Artikel teilen

0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

Meistgelesene Nachrichten des Autors

Titel
Titel
Titel
Titel